Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +1.43% | +0.71% | +5.97% |
04-24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PRECIGEN, INC. | Other Pharmaceuticals | +1.43% | +0.71% | +5.97% | +18.33% | -68.51% | 358M |
Technical Rankings Surperformance
- Stock Market
- Equities
- PGEN Stock
- Charts Precigen, Inc.
- Comparison Chart